Table 1 Main characteristics
Parameter | Training (n = 132) | Validation (n = 120) | P value |
|---|---|---|---|
Sex | .614 | ||
No. of men | 72 (54.5) | 61 (50.8) | |
No. of women | 60 (45.5) | 59 (49.2) | |
Age | .703 | ||
< 60 (years) | 76 (57.6) | 72 (60.0) | |
≥ 60 (years) | 56 (42.4) | 48 (40.0) | |
BMI | 23.86 ± 3.06 | 23.67 ± 2.88 | .618 |
Laboratory findingsa | |||
WBC (109/L) | 5.45 ± 2.15 | 5.20 ± 2.04 | .354 |
FBG (mmol/L) | 8.6 ± 4.2 | 9.3 ± 5.4 | .250 |
FINS (mIU/L) | 14.86 ± 10.37 | 16.33 ± 11.49 | .287 |
AST (IU/mL) | 57.59 ± 68.80 | 69.88 ± 121.65 | .319 |
ALT (IU/mL) | 86.45 ± 145.88 | 87.22 ± 169.00 | .969 |
GGT (IU/mL) | 92.16 ± 118.81 | 77.40 ± 106.36 | .302 |
ALP (IU/mL) | 98.39 ± 60.50 | 87.78 ± 67.94 | .191 |
Platelet count (109/L) | 151.96 ± 59.70 | 148.97 ± 68.49 | .711 |
Cholesterol (mmol/L) | 3.96 ± 1.00 | 4.04 ± 0.92 | .527 |
TG (mmol/L) | 1.80 ± 1.21 | 1.60 ± 1.05 | .106 |
INR | 1.17 ± 0.18 | 1.17 ± 0.15 | .774 |
APRI | 1.17 ± 1.58 | 1.52 ± 3.31 | .275 |
FIB-4 | 2.16 ± 1.67 | 2.69 ± 3.42 | .117 |
Histologic activity grade | .271 | ||
A0 | 27 (20.5) | 23 (19.2) | .875 |
A1 | 49 (37.1) | 57 (47.5) | .099 |
A2 | 40 (30.3) | 32 (26.7) | .577 |
A3 | 16 (12.1) | 8 (6.7) | .197 |
Histologic fibrosis stage | .787 | ||
F0 | 11 (8.3) | 10 (8.3) | > .99 |
F1 | 16 (12.1) | 21 (17.5) | .285 |
F2 | 25 (18.9) | 21 (17.5) | .871 |
F3 | 29 (22.0) | 22 (18.3) | .531 |
F4 | 51 (38.6) | 46 (38.3) | .961 |
TE (kPa) | 11.13 ± 5.21 | 11.05 ± 5.87 | .914 |
CK18 (ng/L) | 105.41 ± 28.33 | 103.24 ± 26.67 | .533 |